Summit Therapeutics Inc vs SYSCO Corporation — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while SYSCO Corporation trades at $81.33 (market cap $38.63B). The key difference: SYSCO Corporation is far larger — about 3.7× Summit Therapeutics Inc's market cap, and SYSCO Corporation pays a 2.72% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | SYY | |
|---|---|---|
Market Cap | $10.48B | $38.63B |
Sector | Health | Consumer Staples |
52-Week High | $29.32 | $91.16 |
52-Week Low | $13.05 | $69.30 |
Enterprise Value | $9.90B | $52.11B |
Dividend Yield | — | 2.72% |
Trailing returns across standard periods
Latest headlines on both assets
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →Sysco is the largest U.S. food-service distributor, boasting 17% market share of the highly fragmented food-service distribution industry. Sysco distributes over 400,000 food and nonfood products to restaurants (63% of revenue), healthcare facilities (8%), education and government buildings (8%), travel and leisure (7%), and other locations (14%) where individuals consume away-from-home meals. In fiscal 2022, 82% of the firm's revenue was U.S.-based, with 7% from Canada, 4% from the U.K., 2% from France, and 4% other.
Read more on SYY →